MIGS Archives - Insight Presented by Prime Creative Media Tue, 15 Mar 2022 20:59:34 +0000 en-US hourly 1 https://www.insightnews.com.au/wp-content/uploads/2024/02/cropped-Insight-favicon-32x32.png MIGS Archives - Insight 32 32 Aussie study offers new MIGS head-to-head comparison https://www.insightnews.com.au/aussie-study-offers-new-migs-head-to-head-comparison/ Tue, 15 Mar 2022 02:47:19 +0000 https://www.insightnews.com.au/?p=26097 Australia MIGS market
The Glaukos iStent is one of few MIGS procedures reimbursed as a standalone procedure.

Australian ophthalmologists have published the first independent head-to-head comparison of two leading minimally invasive glaucoma surgery (MIGS) devices, finding no significant difference in intraocularRead More

The post Aussie study offers new MIGS head-to-head comparison appeared first on Insight.

]]> Australia MIGS market
The Glaukos iStent is one of few MIGS procedures reimbursed as a standalone procedure.
Australian ophthalmologists have published the first independent head-to-head comparison of two leading minimally invasive glaucoma surgery (MIGS) devices, finding no significant difference in intraocular
Read More

The post Aussie study offers new MIGS head-to-head comparison appeared first on Insight.

]]> New findings ‘alter forever how we think of MIGS’ – Dr Ike Ahmed https://www.insightnews.com.au/new-findings-alter-forever-how-we-think-of-migs-dr-ike-ahmed/ Mon, 22 Nov 2021 21:51:29 +0000 https://www.insightnews.com.au/?p=23916 Hydrus Microstent
The findings are said to be a "game changer" for glaucoma.

The post New findings ‘alter forever how we think of MIGS’ – Dr Ike Ahmed appeared first on Insight.

]]> Hydrus Microstent
The findings are said to be a "game changer" for glaucoma.
Ivantis has revealed new data from its five-year HORIZON pivotal trial showing its Hydrus Microstent device lowers the rate of visual field loss by 47% versus cataract surgery alone. In what the company
Read More

The post New findings ‘alter forever how we think of MIGS’ – Dr Ike Ahmed appeared first on Insight.

]]> Alcon to acquire Hydrus Microstent MIGS device for AU$640 million https://www.insightnews.com.au/alcon-to-set-to-acquire-hydrus-microstent-migs-device-for-au640/ Mon, 08 Nov 2021 22:34:52 +0000 https://www.insightnews.com.au/?p=23701
Alcon has confirmed its new Unity systems are now registered in Australia, and will be commercially available in 2025. Image: Konektus Photo/Shutterstock.com.

The post Alcon to acquire Hydrus Microstent MIGS device for AU$640 million appeared first on Insight.

]]>
Alcon has confirmed its new Unity systems are now registered in Australia, and will be commercially available in 2025. Image: Konektus Photo/Shutterstock.com.
Multinational ophthalmic company Alcon has agreed to acquire privately-owned Californian firm Ivantis – and its Hydrus Microstent minimally invasive glaucoma surgery (MIGS) device – for an initial
Read More

The post Alcon to acquire Hydrus Microstent MIGS device for AU$640 million appeared first on Insight.

]]> It’s all about the (aqueous) flow https://www.insightnews.com.au/its-all-about-the-aqueous-flow/ Sun, 17 Oct 2021 21:06:21 +0000 https://www.insightnews.com.au/?p=23312 Dr David Lubeck
Dr David Lubeck observing Dr Shamil Patel performing ab-interno canaloplasty with the iTrack.

The post It’s all about the (aqueous) flow appeared first on Insight.

]]> Dr David Lubeck
Dr David Lubeck observing Dr Shamil Patel performing ab-interno canaloplasty with the iTrack.
When it comes to the treatment of glaucoma, there is growing evidence to suggest that the ability to re-establish the natural flow of aqueous humour plays a critical role not only in reducing
Read More

The post It’s all about the (aqueous) flow appeared first on Insight.

]]> New data shows iTrack efficacy as both standalone and combined MIGS procedure https://www.insightnews.com.au/new-data-shows-itrack-efficacy-as-both-standalone-and-combined-migs-procedure/ Tue, 20 Apr 2021 21:23:48 +0000 http://www.insightnews.com.au/?p=19955
The reduction in medication use was also statistically significant in both iTrack groups at 24 months.

The post New data shows iTrack efficacy as both standalone and combined MIGS procedure appeared first on Insight.

]]>
The reduction in medication use was also statistically significant in both iTrack groups at 24 months.
Nova Eye Medical has published two-year data for its iTrack ab-interno canaloplasty procedure, which it says showed an average reduction in mean intraocular pressure (IOP) of 30%, irrespective of whether
Read More

The post New data shows iTrack efficacy as both standalone and combined MIGS procedure appeared first on Insight.

]]> Making a stand for MBGS under Medicare https://www.insightnews.com.au/making-a-stand-for-mbgs-under-medicare/ Tue, 09 Mar 2021 06:02:01 +0000 http://www.insightnews.com.au/?p=19377
The iStent inject W is Glaukos's latest trabecular micro-bypass system.

The post Making a stand for MBGS under Medicare appeared first on Insight.

]]>
The iStent inject W is Glaukos's latest trabecular micro-bypass system.
Advances in glaucoma stent technology far outstripped the Medicare schedule early on, creating a disconnect that had far-reaching consequences. As Australia marks World Glaucoma Week this 7-13
Read More

The post Making a stand for MBGS under Medicare appeared first on Insight.

]]> Public MIGS funding a step closer for iTrack in Australia https://www.insightnews.com.au/public-migs-funding-a-step-closer-for-itrack-in-australia/ Thu, 18 Feb 2021 20:51:17 +0000 http://www.insightnews.com.au/?p=19082
Canaloplasty targets the main sites of outflow resistance in glaucoma: the trabecular meshwork, Schlemm’s canal, and distal collector channels.

The post Public MIGS funding a step closer for iTrack in Australia appeared first on Insight.

]]>
Canaloplasty targets the main sites of outflow resistance in glaucoma: the trabecular meshwork, Schlemm’s canal, and distal collector channels.
Nova Eye Medical has announced an application to secure public funding for its iTrack ab-interno canaloplasty as a standalone minimally invasive glaucoma surgery (MIGS) procedure in Australia has formally
Read More

The post Public MIGS funding a step closer for iTrack in Australia appeared first on Insight.

]]> 2020: a year like no other https://www.insightnews.com.au/2020-a-year-like-no-other/ Thu, 17 Dec 2020 22:33:40 +0000 http://www.insightnews.com.au/?p=18284

The post 2020: a year like no other appeared first on Insight.

]]>
Insight takes a look at the innovations, breakthroughs, setbacks, events and stories that shaped the Australian ophthalmic sector in 2020. 2020 has been a tough year for the nation
Read More

The post 2020: a year like no other appeared first on Insight.

]]> Aussie firm pushes for Medicare wording change to standalone MIGS https://www.insightnews.com.au/aussie-firm-pushes-for-wording-change-to-new-migs-medicare-item/ Thu, 17 Dec 2020 00:39:07 +0000 http://www.insightnews.com.au/?p=18459
The company's sales growth has been driven by its iTrack MIGS device.

The post Aussie firm pushes for Medicare wording change to standalone MIGS appeared first on Insight.

]]>
The company's sales growth has been driven by its iTrack MIGS device.
Nova Eye Medical is seeking a modification to the existing minimally invasive glaucoma surgery (MIGS) Medicare item number that only came into effect in May, stating the current wording has the unintended
Read More

The post Aussie firm pushes for Medicare wording change to standalone MIGS appeared first on Insight.

]]> Aussie firm reveals next-gen MIGS device in pipeline https://www.insightnews.com.au/aussie-firm-reveals-next-gen-migs-device-in-pipeline/ Mon, 31 Aug 2020 21:40:12 +0000 http://www.insightnews.com.au/?p=16458
The company's sales growth has been driven by its iTrack MIGS device.

The post Aussie firm reveals next-gen MIGS device in pipeline appeared first on Insight.

]]>
The company's sales growth has been driven by its iTrack MIGS device.
Adelaide ophthalmic device manufacturer Nova Eye Medical is developing a next generation iTrack glaucoma surgical system to reduce operating times. It is also progressing towards a pivotal US study for
Read More

The post Aussie firm reveals next-gen MIGS device in pipeline appeared first on Insight.

]]>